Published in Cancer on February 01, 1994
Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol (1995) 4.37
Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A (1995) 3.28
Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol (1995) 2.02
ACP Broadsheet No 146: August 1995. Macroscopic examination of prostatic specimens. J Clin Pathol (1995) 1.76
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42
Contrast-enhanced ultrasound imaging of prostate cancer. Rev Urol (2006) 1.13
Optoacoustic imaging of the prostate: development toward image-guided biopsy. J Biomed Opt (2010) 1.12
Novel trends in transrectal ultrasound imaging of prostate gland carcinoma. J Ultrason (2014) 1.04
Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol (2009) 1.03
Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol (2001) 1.01
The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach. Cancer Biomark (2008) 1.00
Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer. Br J Cancer (2001) 0.99
Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol (1999) 0.97
Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. Acad Radiol (2010) 0.97
Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer. Virchows Arch (2005) 0.97
Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? Am J Pathol (2010) 0.95
Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2. Curr Oncol (2006) 0.94
Future perspectives of prostate cancer therapy. Transl Androl Urol (2012) 0.91
Imaging angiogenesis of genitourinary tumors. Nat Rev Urol (2010) 0.90
Image-guided robotic interventions for prostate cancer. Nat Rev Urol (2013) 0.89
The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review). Oncol Lett (2014) 0.89
Molecular and genetic prognostic factors of prostate cancer. World J Urol (2003) 0.89
The role of angiogenesis in prostate and other urologic cancers: a review. CMAJ (2001) 0.88
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC). Invest New Drugs (2010) 0.87
A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation. Magn Reson Imaging (2014) 0.86
Angiogenesis in oral squamous cell carcinoma. Acta Otorhinolaryngol Ital (2005) 0.86
Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma? Eur Radiol (2003) 0.86
Effects of TRPM8 on the proliferation and angiogenesis of prostate cancer PC-3 cells in vivo. Oncol Lett (2011) 0.85
Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy. Invest New Drugs (1997) 0.82
CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth. Mol Cancer Ther (2009) 0.82
Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective. MAGMA (2008) 0.82
Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option? Arch Med Sci (2012) 0.81
Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging (2015) 0.81
Prostate cancer: epidemiology and screening. Rev Urol (2000) 0.81
On the relationship between microbubble fragmentation, deflation and broadband superharmonic signal production. Ultrasound Med Biol (2015) 0.80
Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis. World J Gastroenterol (2007) 0.80
Prostate ultrasound--for urologists only? Cancer Imaging (2005) 0.79
Feasibility of measuring prostate perfusion with arterial spin labeling. NMR Biomed (2012) 0.78
Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls. Transl Oncol (2014) 0.78
Lack of correlation between microvascular density and pathological features and outcomes in sinonasal and oral mucosal melanomas. Head Neck Pathol (2011) 0.77
Optimization of Contrast-to-Tissue Ratio Through Pulse Windowing in Dual-Frequency "Acoustic Angiography" Imaging. Ultrasound Med Biol (2015) 0.77
Early diagnosis and staging of prostate cancer. Rev Urol (2003) 0.77
Computational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis. Theor Biol Med Model (2014) 0.75
Prognostic significance of angiogenesis by Chalkley counting in node negative cancer of the ampulla of Vater. J Korean Med Sci (2012) 0.75
Inhibitory effect of midkine-binding peptide on tumor proliferation and migration. Int J Clin Exp Pathol (2015) 0.75
Hidden Markov models in computational biology. Applications to protein modeling. J Mol Biol (1994) 31.57
Dirichlet mixtures: a method for improved detection of weak but significant protein sequence homology. Comput Appl Biosci (1996) 19.74
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell (2000) 11.10
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1998) 10.74
Objective structured assessment of technical skill (OSATS) for surgical residents. Br J Surg (1997) 7.54
Stochastic context-free grammars for tRNA modeling. Nucleic Acids Res (1994) 6.29
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature (1985) 5.10
Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell (1986) 4.89
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med (1992) 4.71
A Social Study of Hospital Treatment. Br Med J (1945) 4.24
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science (1994) 4.22
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14
Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (1995) 3.90
The association of school environments with youth physical activity. Am J Public Health (2001) 3.88
Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet (2011) 3.70
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med (1995) 3.34
lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell (1987) 3.33
Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem (1995) 3.13
Cost comparison: a desflurane- versus a propofol-based general anesthetic technique. Anesth Analg (1994) 3.09
Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc Natl Acad Sci U S A (1991) 3.06
Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med (1980) 3.04
Introduction and audit of a general practice antibiotic formulary. J R Coll Gen Pract (1988) 3.00
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther (2000) 2.94
Assessment of technical skills transfer from the bench training model to the human model. Am J Surg (1999) 2.90
The urethral pressure profile. Br J Urol (1969) 2.88
Heart rate responses to social interactions in free-moving rhesus macaques (Macaca mulatta): a pilot study. J Comp Psychol (1999) 2.86
p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci U S A (1996) 2.58
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A (1997) 2.54
Vertical integration: exploration of a popular strategic concept. Health Care Manage Rev (1986) 2.50
Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol (2001) 2.42
Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol (1997) 2.40
Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costs. Arch Intern Med (1993) 2.36
Angiogenesis in skeletal and cardiac muscle. Physiol Rev (1992) 2.34
Cationic bactericidal peptides. Adv Microb Physiol (1995) 2.33
Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle. Proc Natl Acad Sci U S A (1999) 2.30
Induction of DNA polymerase in mouse L cells. J Mol Biol (1973) 2.28
The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol (1993) 2.24
Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol (2001) 2.22
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol (2000) 2.18
Taste genes associated with dental caries. J Dent Res (2010) 2.17
Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet (1968) 2.14
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet (1999) 2.14
SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell (1987) 2.13
Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. J Appl Physiol (1985) (1992) 2.06
Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin Cancer Res (1996) 1.98
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res (1991) 1.94
Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis (1996) 1.91
Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol (1994) 1.88
Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol (1999) 1.88
Location of BRCA1 in human breast and ovarian cancer cells. Science (1996) 1.88
Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol (1989) 1.85
Characterization of early simian virus 40 transcriptional complexes: late transcription in the absence of detectable DNA replication. Proc Natl Acad Sci U S A (1977) 1.82
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res (2001) 1.81
BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol (2000) 1.80
Superior oblique tendon sheath syndrome of Brown. Am J Ophthalmol (1975) 1.76
Inhibition of HIV-1 infection by the beta-chemokine MDC. Science (1997) 1.75
Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol (1992) 1.74
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. Gene Ther (2002) 1.73
Inherited chondrodysplasia punctata due to a deletion of the terminal short arm of an X chromosome. N Engl J Med (1984) 1.70
Modification of SV40 T antigen by poly ADP-ribosylation. Cell (1981) 1.70
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene (2010) 1.69
Variations in the Position and Development of the Kidneys. J Anat Physiol (1894) 1.69
A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth. J Virol (1986) 1.68
Somatostatin. Recent Prog Horm Res (1975) 1.67
Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation (1990) 1.66
Regulatory peptides of the hypothalamus. Annu Rev Physiol (1977) 1.64
Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology (1991) 1.63
Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol (2000) 1.59
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer (2003) 1.58
Diagnosis of fastidious enteric adenoviruses 40 and 41 in stool specimens. J Clin Microbiol (1984) 1.57
P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. Shock (1999) 1.55
Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev (2001) 1.53
The detection and quantitation of SV40 nucleic acid sequences using single-stranded SV40 DNA probes. Cold Spring Harb Symp Quant Biol (1975) 1.53
Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene (2010) 1.52
Intrinsic disc pressure as a measure of integrity of the lumbar spine. Spine (Phila Pa 1976) (1988) 1.52
Chlamydia trachomatis and Neisseria gonorrhoeae infection and the sexual behaviour of men who have sex with men. Sex Transm Infect (2006) 1.52
Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea. Gastroenterology (1995) 1.51
Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell (1985) 1.51
Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol (1997) 1.51
Escherichia Coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease. Gastroenterology (1969) 1.50
Terminal riboadenylate transferase: a poly A polymerase in purified vaccinia virus. J Virol (1973) 1.49
Silico-mycobacterial disease in sandblasters. Am Rev Respir Dis (1974) 1.48
Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous. Br J Dermatol (2009) 1.48
Genetic structure and diversity among sheep breeds in the United States: identification of the major gene pools. J Anim Sci (2011) 1.48
A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma. Cancer (1999) 1.43
Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules. Aliment Pharmacol Ther (2012) 1.43
Synthesis and characterization of late lytic simian virus 40 RNA from transcriptional complexes. Virology (1977) 1.42
Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer (2005) 1.42
Genome localization of simian virus 40 RNA species. J Virol (1976) 1.41
Cisplatin-based combination chemotherapy in the treatment of advanced-stage testicular cancer: cost-benefit analysis. J Natl Cancer Inst (1990) 1.41
Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment. J Urol (2000) 1.41
Tracking of fluid in urethra by simultaneous electric impedance measurement at three sites. Urol Int (1983) 1.40
Pain palliation with strontium-89 in children with metastatic disease. Med Pediatr Oncol (1996) 1.39
Prospective study of the incidence and outcome of intra-abdominal hypertension and the abdominal compartment syndrome. Br J Surg (2002) 1.38
Comparison of direct and indirect blood pressure measurement in anesthetized dogs. Lab Anim Sci (1991) 1.37
AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res (2001) 1.35